LSTM Home > LSTM Research > LSTM Online Archive

Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses

Downloads

Downloads per month over past year

Gordon, Stephen ORCID: https://orcid.org/0000-0001-6576-1116, Malamba, R., Mthunthama, N., Jarman, E. R., Jambo, Kondwani C., Jere, K., Zijlstra, E. E., Molyneux, Malcolm E, Dennis, J. and French, Neil (2008) 'Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses'. Vaccine, Vol 26, Issue 42, pp. 5400-5406.

[img]
Preview
Text
SB_Gordon_Inhaled_delivery_of_23-valent.pdf - Other
Available under License Creative Commons Attribution.

Download (681kB)

Abstract

We compared the effect of intramuscular vs. inhaled 23-valent pneumococcal capsular polysaccharide vaccine (23-PPV) oil pulmonary mucosal immunoglobulin levels. Bronchoalveolar lavage (BAL) and serum were collected from 33 adults before and I month after injected (n = 16) or inhaled (it = 17) 23-PPV. Levels of pneumococcal capsule-specific IgG and IgA to types 1, 9V and 14 were measured in each sample. Injected 23-PPV produced a significant increase in types 1, 9V and 14 capsule-specific IgG and type I IgA in both serum and BAL (type I geometric mean BAL IgG 9.8 ng/ml post-vaccine vs. 5 ng/ml pre-vaccine, p = 0.01; type 9V geo mean 5.6 ng/ml vs. 2.7 ng/ml, p = 0.001; type 14 geo mean 23.6 ng/ml vs. 6.2 ng/ml, p = 0.02). Inhaled vaccine produced no response in either BAL or serum. (C) 2008 Elsevier Ltd. All rights reserved.

Item Type: Article
Additional Information: PubMed Sponsored document from Vaccine
Uncontrolled Keywords: inhaled pneumococcal vaccine lung pneumonia streptococcus pneumoniae immunoglobulin mucosa bronchoalveolar lavage polysaccharide human alveolar macrophages infected malawian adults placebo-controlled trial streptococcus-pneumoniae conjugate vaccine inhalative vaccination double-blind disease efficacy antibody
Subjects: QW Microbiology and Immunology > Immune Responses > QW 700 Infection. Mechanisms of infection and resistance.
QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 805 Vaccines. Antitoxins. Toxoids
QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 806 Vaccination
WA Public Health > Preventive Medicine > WA 108 Preventive health services. Preventive medicine. Travel Medicine.
WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
WA Public Health > Preventive Medicine > WA 115 Immunization
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 202 Pneumonia (General or not elsewhere classified)
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 204 Pneumococcal pneumonia. Staphylococcal pneumonia
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 217 Pneumococcal infections
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 240 Bacteremia. Sepsis. Toxemias
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 250 Staphylococcal infections
Faculty: Department: Groups (2002 - 2012) > Clinical Group
Digital Object Identifer (DOI): https://doi.org/10.1016/j.vaccine.2008.07.082
Depositing User: Users 43 not found.
Date Deposited: 25 Aug 2010 14:35
Last Modified: 07 Oct 2019 08:23
URI: https://archive.lstmed.ac.uk/id/eprint/795

Statistics

View details

Actions (login required)

Edit Item Edit Item